Alimta Approved for Advanced Lung Cancer - Cancer Information (Cancers, Symptoms, Treatment) on MedicineNet.com

Font Size

Alimta Approved as Maintenance Therapy for Advanced Lung Cancer

MONDAY, July 6 (HealthDay News) -- The drug Alimta (pemetrexed) has been approved by the U.S. Food and Drug Administration to prevent progression of certain types of advanced or metastatic (spreading) lung cancer, the agency said Monday.

Latest Cancer News

The drug, which hinders the needed absorption by certain tumors of B-vitamin folate, is newly approved for people whose tumor has shrunk or whose cancer has stabilized after chemotherapy.

Alimta was first approved in 2004 to treat the asbestos-linked cancer mesothelioma and, later, as an initial therapy for advanced non-small cell lung cancer, the FDA said in a news release.

Possible side effects may include blood cell damage, fatigue, nausea, loss of appetite, extremity numbness, and rash, the FDA said.

The drug is produced by Indianpolis-based Eli Lilly & Co.

-- Scott Roberts

News Articles
1
2
3
4
5
Next Article: Morphine May Help Tumors Spread in Cancer Patients »

Printer-Friendly Format

Email to a Friend

Health categories:	Slideshows \| Diseases & Conditions \| Symptoms & Signs \| Procedures & Tests \| Medications \| Health & Living \| News & Views \| Medical Dictionary
Popular health centers:	Allergies \| Arthritis \| Cancer \| Diabetes \| Digestion \| Healthy Kids \| Heart \| Men's Health \| Mental Health \| Women's Health \| More...
Publications:	ePublications (PDFs) \| XML News via RSS \| Audio Podcasts \| Email Newsletters
MedicineNet.com:	About Us \| Privacy Policy \| Site Map \| WebMD® \| Medscape® \| eMedicine® \| eMedicineHealth® \| RxList®

Alimta Approved as Maintenance Therapy for Advanced Lung Cancer

Latest Cancer News

Cancer

From WebMD

Cancer Resources

Featured Centers

Health Solutions From Our Sponsors

Daily Health News